2022
DOI: 10.22541/au.164873341.16568307/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The Development of Locoregional Therapies as a Strategy for Reducing Cervical Cancer Mortality in Low to Middle Income Countries.

Abstract: Early detection concomitant with appropriate treatment intervention for pre-invasive cervical cancer has proved effective in the ‘war on cervical cancer’ in the developed world. Unfortunately, these advances have not been mirrored in the developing world, where incidence and mortality rates are currently approximately 90% of the world’s burden. Due to economic, infrastructure and skilled personnel constraints, the impact of cytology screening as a method for early detection and reducing mortality rates from ce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 86 publications
0
2
0
Order By: Relevance
“…For early diagnosis of cervical cancer, its screening using cervical cytology specimens is performed based on the Bethesda System [ 21 ]. However, compared to high-income countries, cytology is less extensively employed in low- and middle-income countries due to a lack of healthcare infrastructure and a paucity of cytologists or cytopathologists [ 18 – 20 , 22 , 23 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…For early diagnosis of cervical cancer, its screening using cervical cytology specimens is performed based on the Bethesda System [ 21 ]. However, compared to high-income countries, cytology is less extensively employed in low- and middle-income countries due to a lack of healthcare infrastructure and a paucity of cytologists or cytopathologists [ 18 – 20 , 22 , 23 ].…”
Section: Introductionmentioning
confidence: 99%
“…Cervical cancer is the fourth most frequent cancer in women worldwide, with an estimated 604,000 new cases and 342,000 deaths in 2020 [16], with low-and middle-income countries accounting for approximately 90% of the cases and deaths [17][18][19][20]. For early diagnosis of cervical cancer, its screening using cervical cytology specimens is performed based on the Bethesda System [21].…”
Section: Introductionmentioning
confidence: 99%